Systematic Mediastinal Lymphadenectomy or Mediastinal Lymph Node Sampling in Patients With Pathological Stage I NSCLC: A Meta-Analysis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  World Journal of Surgery

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00268-014-2804-8PMID 25277979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of lobe-specific mediastinal lymphadenectomy versus systematic mediastinal lymphadenectomy for clinical stage T₁a N₀ M₀ non-small cell lung cancer.

  2013cited by this paper
• Surgery for nonsmall cell lung cancer

  2013cited by this paper
• Cancer treatment and survivorship statistics, 2012

  2012cited by this paper
• Screening-Detected Lung Cancers: Is Systematic Nodal Dissection Always Essential?

  2011cited by this paper
• Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.

  2011cited by this paper
• Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.

  2010cited by this paper
• Fluorodeoxyglucose Uptake Measured by Positron Emission Tomography and Standardized Uptake Value Predicts Long-Term Survival of CT Screening Detected Lung Cancer in Heavy Smokers

  2009cited by this paper
• The new lung cancer staging system.

  2009cited by this paper
• Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.

  2008cited by this paper
• Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

  2008cited by this paper
• Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.

  2008cited by this paper
• Mediastinal Lymph Node Dissection Affects Survival in Patients with Stage I Non-Small Cell Lung Cancer

  2008cited by this paper
• Effect of mediastinal lymph nodes sampling in patients with clinical stage I non-small cell lung cancer.

  2008cited by this paper
• Survival of patients with stage I lung cancer detected on CT screening.

  2006cited by this paper
• Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials

  2006cited by this paper
• Non-small cell lung cancer: Clinical practice guidelines in oncology

  2006cited by this paper
• Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.

  2006cited by this paper
• Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer.

  2006cited by this paper
• Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?

  2005cited by this paper
• Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.

  2005cited by this paper
• Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.

  2003cited by this paper
• Current Concepts in the Mediastinal Lymph Node Staging of Nonsmall Cell Lung Cancer

  2003cited by this paper
• Tumor Dimension and Prognosis in Surgically Treated Lung Cancer: For Intentional Limited Resection

  2003cited by this paper
• A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer.

  2002cited by this paper
• Intraoperative sentinel lymph node mapping in non-small-cell lung cancer improves detection of micrometastases.

  2002cited by this paper
• Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer

  2000cited by this paper
• Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group.

  2000cited by this paper
• Clinical and surgical staging of non-small cell lung cancer.

  2000cited by this paper
• Is radical lymphadenectomy a valid oncologic procedure?

  1999cited by this paper
• The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

  1998cited by this paper
• Systematic Lymph Node Dissection for Clinically Diagnosed Peripheral Non-Small-Cell Lung Cancer Less Than 2 cm in Diameter

  1998cited by this paper
• Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial.

  1998cited by this paper
• Regional lymph node classification for lung cancer staging.

  1997cited by this paper
• Eastern Cooperative Oncology Group (ECOG).

  1996cited by this paper
• Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter.

  1990cited by this paper
• The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

  1985cited by this paper

• Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience

  2025cites this paper
• Lymphadenectomy in the treatment of sarcomas – indications and technique

  2024cites this paper
• Lymph node evaluation and surgical procedure selection for non-small cell lung cancer

  2024cites this paper
• The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer.

  2023cites this paper
• Long-Term Oncologic Outcomes in Robot-Assisted and Video-Assisted Lobectomies for Non-Small Cell Lung Cancer

  2023cites this paper
• The Role of Lymphadenectomy in Early-Stage NSCLC

  2023cites this paper
• Selective Mediastinal Lymphadenectomy or Complete Mediastinal Lymphadenectomy for Clinical Stage I Non-Small Cell Lung Cancer: A Meta-Analysis

  2021cites this paper
• Evaluating Transcervical Lymphadenectomy in Systematic Diagnosis of Lung Cancer

  2021cites this paper
• Comparison between radiofrequency ablation and sublobar resections for the therapy of stage I non-small cell lung cancer: a meta-analysis

  2020cites this paper
• Preoperative 3D-CT bronchography and angiography facilitates single-direction uniportal thoracoscopic anatomic lobectomy.

  2019cites this paper
• Survival after lobectomy versus sub-lobar resection in elderly with stage I NSCLC: a meta-analysis

  2019cites this paper
• Prognosis analysis of lobectomy and sublobar resection in patients ≥75 years old with pathological stage I invasive lung adenocarcinoma of ≤3 cm: a propensity score matching-based analysis

  2019cites this paper
• Robotic lobectomy for lung cancer: initial experience of a single institution in Korea.

  2019cites this paper
• Is more better?—for mediastinal lymph nodes this issue is still not dissected

  2018cites this paper
• Is systematic lymph node dissection mandatory or is sampling adequate in patients with stage I non-small-cell lung cancer?

  2018cites this paper
• Mediastinal lymph node dissection in open thoracic surgery

  2017cites this paper